1887

Chapter 20 : Human Immunodeficiency Virus, , , and Species

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Human Immunodeficiency Virus, , , and Species, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817947/9781555812447_Chap20-1.gif /docserver/preview/fulltext/10.1128/9781555817947/9781555812447_Chap20-2.gif

Abstract:

Human immunodeficiency virus (HIV) type 1 and 2 (HIV-1 and HIV-2) infections have had a profound impact on morbidity and mortality worldwide. AIDS has evolved from an illness of men who have sex with men and of injection drug users into a large and expanding pandemic of heterosexually transmitted disease affecting men, women, and children across the globe. This chapter concentrates on the interaction between HIV-1, immune suppression and reconstitution, and opportunistic microbes such as , and species.

Citation: Isturiz R, Gotuzzo E. 2002. Human Immunodeficiency Virus, , , and Species, p 389-400. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch20
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817947.chap20
1. Alcabes, P.,, A. Munoz,, D. Vlahov,, and G. H. Friedland. 1993. Incubation period of human immunodeficiency virus. Epidemiol. Rev. 15: 303 318.
2. Alvar, J.,, C. Canavate,, B. Gutierrez-Solar,, M. Jimenez,, F. Laguna,, R. Lopez-Velez,, R. Molina,, and J. Moreno. 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10: 298 319.
3. Alvar, J.,, B. Gutierrez-Solar,, I. Pachon,, E. Calbacho,, M. Ramirez,, R. Valles,, J. L. Guillen,, C. Canavate,, and C. Amela. 1996. AIDS and Leishmania infantum. New approaches for a new epidemiological problem. Clin. Dermatol. 14: 541 546.
4. Blumenfeld, W.,, O. McCook,, and J. M. Griffiss. 1991. In vitro aggregation of macrophages around human-derived Pneumocystis carinii. J. Protozool. 38: 32S 33S.
5. Canessa, A.,, V. Del Bono,, F. Miletich,, and V. Pistoia. 1992. Serum cytokines in toxoplas- mosis: increased levels of interferon-gamma in immunocompetent patients with lymphadenopathy but not in AIDS patients with encephalitis. J. Infect. Dis. 165: 1168 1170.
6. Cao, Y.,, L. Qin,, L. Zhang,, J. Safrit,, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332: 201 208.
7. Carpenter, C. C.,, D. A. Cooper,, M. A. Fischl,, J. M. Gatell,, B. G. Gazzard,, S. M. Hammer,, M. S. Hirsch,, D. M. Jacobsen,, D. A. Katzenstein,, J. S. Montaner,, D. D. Richman,, M. S. Saag,, M. Schechter,, R. T. Schooley,, M. A. Thompson,, S. Vella,, P. G. Yeni,, and P. A. Volberding. 2000. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 283: 381 390.
8. Carpenter, C. C.,, M. A. Fischl,, S. M. Hammer,, M. S. Hirsch,, D. M. Jacobsen,, D. A. Katzenstein,, J. S. Montaner,, D. D. Richman,, M. S. Saag,, R. T. Schooley,, M. A. Thompson,, S. Vella,, P. G. Yeni,, and P. A. Volberding. 1998. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA 280: 78 86.
9. Carrega, G.,, A. Canessa,, P. Argenta,, M. Cruciani,, and D. Bassetti. 1995. T cell blastogenic responses to Toxoplasma gondii trophozoites among HIV-infected patients. AIDS Res. Hum. Retrovir. 11: 741 746.
10. Centers for Disease Control and Prevention. 1989. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. Morb. Mortal. Wkly. Rep. 38: 17.
11. Chen, W.,, E. A. Havell,, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60: 1279 1284.
12. Chen, W.,, E. A. Havell,, L. L. Moldawer,, K. W. McIntyre,, R. A. Chizzonite,, and A. G. Harmsen. 1992. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J. Exp. Med. 176: 713 718.
13. Cheng, V. C.,, K. Y. Yuen,, W. M. Chan,, S. S. Wong,, E. S. Ma,, and R. M. Chan. 2000. Immunorestitution disease involving the innate and adaptive response. Clin. Infect. Dis. 30: 882 892.
14. Ciricillo, S. F.,, and M. L. Rosenblum. 1990. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J. Neurosurg. 73: 720 724.
15. Clarke, J. R.,, and D. Israel-Biet. 1996. Interactions between opportunistic microorganisms and HIV in the lung. Thorax 51: 875 877.
16. Clerici, M.,, N. I. Stocks,, R. A. Zajac,, R. N. Boswell,, D. R. Lucey,, C. S. Via,, and G. M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virusseropositive patients. Independence of CD4 + cell numbers and clinical staging. J. Clin. Invest. 84: 1892 1899.
17. Cohen, O.,, C. Cicala,, M. Vaccarezza,, and A. S. Fauci,. 2000. The immunology of human immunodeficiency virus infection, p. 1374 1397. In G. L. Mandell,, J. E. Bennett,, and R. F. Dolin (ed.), Principles and Practice of Infectious Diseases, 5th ed. Churchill Livingstone, Philadelphia, Pa.
18. Condom, M. J.,, B. Clotet,, G. Sirera,, F. Milla,, and M. Foz. 1989. Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 111: 767 768.
19. Delemarre, F. G.,, A. Stevenhagen,, F. P. Kroon,, M. Y. van Eer,, P. L. Meenhorst,, and R. van Furth. 1995. Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2. AIDS 9: 441 445.
20. Delemarre, F. G.,, A. Stevenhagen,, F. P. Kroon,, and R. van Furth. 1998. Reduced toxoplasmastatic activity of monocytes from AIDS patients: a role for granulocyte-macrophage colonystimulating factor. Scand. J. Immunol. 47: 163 166.
21. Derouin, F.,, L. Gerard,, R. Farinotti,, C. Maslo,, and C. Leport. 1998. Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19: 50 54.
22. Desjeux, P.,, B. Piot,, K. O’Neill,, and J. P. Meert. 2001. Co-infections of leishmania/HIV in south Europe. Med. Trop. 61: 187 193.
23. Desmonts, G.,, and J. Couvreur. 1974. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull. N. Y. Acad. Med. 50: 146 159.
24. Elvin, K.,, A. Bjorkman,, N. Heurlin,, B. M. Eriksson,, L. Barkholt,, and E. Linder. 1994. Seroreactivity to Pneumocystis carinii in patients with AIDS versus other immunosuppressed patients. Scand. J. Infect. Dis. 26: 33 40.
25. Elvin, K.,, C. Lidman,, E. Tynell,, E. Linder,, and A. Bjorkman. 1994. Natural history of asymptomatic and symptomatic Pneumocystis carinii infection in HIV infected patients. Scand. J. Infect. Dis. 26: 643 651.
26. Ezekowitz, R. A.,, D. J. Williams,, H. Koziel,, M. Y. Armstrong,, A. Warner,, F. F. Richards,, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351: 155 158.
27. Foudrinier, F.,, D. Aubert,, D. Puygauthier- Toubas,, C. Rouger,, I. Beguinot,, P. Halbout,, P. Lemaire,, C. Marx-Chemla,, and J. M. Pinon. 1996. Detection of Toxoplasma gondii in immunodeficient subjects by gene amplification: influence of therapeutics. Scand. J. Infect. Dis. 28: 383 386.
28. Fournier, S.,, C. Rabian,, C. Alberti,, M. V. Carmagnat,, J. F. Garin,, D. Charron,, F. Derouin,, and J. M. Molina. 2001. Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon-gamma production in the presence of Toxoplasma gondii antigens. J. Infect. Dis. 183: 1586 1591.
29. French, M. A.,, and P. Price. 2001. Immune restoration disease in HIV-infected patients after antiretroviral therapy. Clin. Infect. Dis. 32: 325 326.
30. Frenkel, J. K.,, B. M. Nelson,, and J. Arias- Stella. 1975. Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects. Hum. Pathol. 6: 97 111.
31. Greene, W. C. 1991. The molecular biology of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 324: 308 317.
32. Hagler, D. N.,, G. S. Deepe,, C. L. Pogue,, and P. D. Walzer. 1988. Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection. Clin. Exp. Immunol. 74: 7 13.
33. Hanano, R.,, and S. H. Kaufmann. 1998. Immune responses to naturally acquired Pneumocystis carinii in gene disruption mutant mice. Res. Immunol. 149: 429 435, 514.
34. Hanano, R.,, and S. H. Kaufmann. 1998. Pneumocystis carinii and the immune response in disease. Trends Microbiol. 6: 71 75.
35. Hanano, R.,, K. Reifenberg,, and S. H. Kaufmann. 1998. Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii. Infect. Immun. 66: 305 314.
36. Helweg-Larsen, J.,, T. L. Benfield,, J. Eugen- Olsen,, J. D. Lundgren,, and B. Lundgren. 1999. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 354: 1347 1351.
37. Herwaldt, B. L. 1999. Leishmaniasis. Lancet 354: 1191 1199.
38. Hu, D. J.,, T. J. Dondero,, M. A. Rayfield,, J. R. George,, G. Schochetman,, H. W. Jaffe,, C. C. Luo,, M. L. Kalish,, B. G. Weniger,, C. P. Pau,, C. A. Schable,, and J. W. Curran. 1996. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA 275: 10 216.
39. Jimenez, M. I.,, F. Laguna,, F. de la Torre,, F. Solis,, F. Pratlong,, and J. Alvar. 1995. New Leishmania (Leishmania) infantum zymodemes responsible for visceral leishmaniasis in patients coinfected with HIV in Spain. Trans. R. Soc. Trop. Med. Hyg. 89: 33.
40. Kassler, W. J.,, C. Haley,, W. K. Jones,, A. R. Gerber,, E. J. Kennedy,, and J. R. George. 1995. Performance of a rapid, on-site human immunodeficiency virus antibody assay in a public health setting. J. Clin. Microbiol. 33: 2899 2902.
41. Kleinman, S.,, M. P. Busch,, L. Hall,, R. Thomson,, S. Glynn,, D. Gallahan,, H. E. Ownby, and A. E. Williams for the Retrovirus Epidemiology Donor Study. 1998. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. JAMA 280: 1080 1085.
42. Kovacs, J. A.,, J. L. Halpern,, J. C. Swan,, J. Moss,, J. E. Parrillo,, and H. Masur. 1988. Identification of antigens and antibodies specific for Pneumocystis carinii. J. Immunol. 140: 2023 2031.
43. Koziel, H.,, X. Li,, M. Y. Armstrong,, F. F. Richards,, and R. M. Rose. 2000. Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. Am. J. Respir. Cell Mol. Biol. 23: 452 459.
44. Laguna, F.,, J. Garcia-Samaniego,, V. Soriano,, E. Valencia,, C. Redondo,, M. J. Alonso,, and J. M. Gonzalez-Lahoz. 1994. Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin. Infect. Dis. 19: 48 53.
45. Lane, H. C.,, H. Masur,, L. C. Edgar,, G. Whalen,, A. H. Rook,, and A. S. Fauci. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309: 453 458.
46. Laursen, A. L.,, and P. L. Andersen. 1998. Low levels of IgG antibodies against Pneumocystis carinii among HIV-infected patients. Scand. J. Infect. Dis. 30: 495 499.
47. Laursen, A. L.,, J. Rungby,, and P. L. Andersen. 1995. Decreased activation of the respiratory burst in neutrophils from AIDS patients with previous Pneumocystis carinii pneumonia. J. Infect. Dis. 172: 497 505.
48. Leport, C.,, G. Chene,, P. Morlat,, B. J. Luft,, F. Rousseau,, S. Pueyo,, R. Hafner,, J. Miro,, J. Aubertin,, R. Salamon,, J. L. Vilde, ANRS 005-ACTG 154 Group Members, Agence Nationale de Recherche sur le SIDA, and AIDS Clinical Trial Group. 1996. Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. J. Infect. Dis. 173: 91 97.
49. Levy, R. M.,, C. M. Mills,, J. P. Posin,, S. G. Moore,, M. L. Rosenblum,, and D. E. Bredesen. 1990. The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study. J. Acquir. Immune Defic. Syndr. 3: 461 471.
50. Limper, A. H. 1995. Adhesive glycoproteins in the pathogenesis of Pneumocystis carinii pneumonia: host defense or microbial offense? J. Lab. Clin. Med. 125: 12 13.
51. Luft, B. J.,, and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15: 211 222.
52. Macatonia, S. E.,, R. Lau,, S. Patterson,, A. J. Pinching,, and S. C. Knight. 1990. Dendritic cell infection, depletion and dysfunction in HIVinfected individuals. Immunology 71: 38 45.
53. Mary, C.,, D. Lamouroux,, S. Dunan,, and M. Quilici. 1992. Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes. Am. J. Trop. Med. Hyg. 47: 764 771.
54. Masur, H., 2000. Management of opportunistic infections associated with human immunodeficiency virus infection, p. 1500 1519. In G. L. Mandell,, J. E. Bennett,, and R. F. Dolin (ed.), Principles and Practice of Infectious Diseases, 5th ed. Churchill Livingstone, Philadelphia, Pa..
55. Matsumoto, Y.,, and Y. Yoshida. 1984. Sporogony in Pneumocystis carinii: synaptonemal complexes and meiotic nuclear divisions observed in precysts. J. Protozool. 31: 420 428.
56. Meshnick, S. R. 1999. Drug-resistant Pneumocystis carinii. Lancet 354: 1318 1319.
57. Meyer, L.,, M. Magierowska,, J. B. Hubert,, C. Rouzioux,, C. Deveau,, F. Sanson,, P. Debre,, J. F. Delfraissy,, I. Theodorou, and the SEROCO Study Group. 1997. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 11: F73 F78.
58. Minkoff, H.,, J. S. Remington,, S. Holman,, R. Ramirez,, S. Goodwin,, and S. Landesman. 1997. Vertical transmission of toxoplasma by human immunodeficiency virus-infected women. Am. J. Obstet. Gynecol. 176: 555 559.
59. Montoya, J. G.,, and J. S. Remington,. 2000. Toxoplasma gondii, p. 2858 2888. In G. L. Mandell,, J. E. Bennett,, and R. F. Dolin (ed.), Principles and Practice of Infectious Diseases, 5th ed. Churchill Livingstone, Philadelphia, Pa.
60. Murray, H. W.,, B. Y. Rubin,, H. Masur,, and R. B. Roberts. 1984. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310: 883 889.
61. Murray, H. W.,, K. Welte,, J. L. Jacobs,, B. Y. Rubin,, R. Mertelsmann,, and R. B. Roberts. 1985. Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. J. Clin. Investig. 76: 1959 1964.
62. Narasimhan, S.,, M. Y. Armstrong,, K. Rhee,, J. C. Edman,, F. F. Richards,, and E. Spicer. 1994. Gene for an extracellular matrix receptor protein from Pneumocystis carinii. Proc. Natl. Acad. Sci. USA 91: 7440 7444.
63. Navia, B. A.,, C. K. Petito,, J. W. Gold,, E. S. Cho,, B. D. Jordan,, and R. W. Price. 1986. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann. Neurol. 19: 224 238.
64. Nebuloni, M.,, A. Pellegrinelli,, A. Ferri,, A. Tosoni,, S. Bonetto,, P. Zerbi,, R. Boldorini,, L. Vago,, and G. Costanzi. 2000. Etiology of microglial nodules in brains of patients with acquired immunodeficiency syndrome. J. Neurovirol. 6: 46 50.
65. Palella, F. J., Jr.,, K. M. Delaney,, A. C. Moorman,, M. O. Loveless,, J. Fuhrer,, G. A. Satten,, D. J. Aschman,, S. D. Holmberg, and the HIV Outpatient Study Investigators. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338: 853 860.
66. Pantaleo, G.,, S. Menzo,, M. Vaccarezza,, C. Graziosi,, O. J. Cohen,, J. F. Demarest,, D. Monteflori,, J. M. Orenstein,, C. Fox,, L. K. Schrager, et al. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332: 209 216.
67. Pavesio, C. E.,, M. L. Chiappino,, P. Y. Setzer,, and B. A. Nichols. 1992. Toxoplasma gondii: differentiation and death of bradyzoites. Parasitol. Res. 78: 1 9.
68. Peglow, S. L.,, A. G. Smulian,, M. J. Linke,, C. L. Pogue,, S. Nurre,, J. Crisler,, J. Phair,, J. W. Gold,, D. Armstrong,, and P. D. Walzer. 1990. Serologic responses to Pneumocystis carinii antigens in health and disease. J. Infect. Dis. 161: 296 306.
69. Piarroux, R.,, F. Gambarelli,, H. Dumon,, M. Fontes,, S. Dunan,, C. Mary,, B. Toga,, and M. Quilici. 1994. Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniasis in immunocompromised patients. J. Clin. Microbiol. 32: 746 749.
70. Pierce, M. A.,, M. D. Johnson,, R. J. Maciunas,, M. J. Murray,, G. S. Allen,, M. A. Harbison,, J. L. Creasy,, and R. M. Kessler. 1995. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann. Intern. Med. 123: 594 598.
71. Pifer, L. L.,, H. B. Niell,, S. B. Langdon,, S. Baltz,, S. T. Clark,, C. C. Edwards,, and D. R. Woods. 1987. Evidence for depressed humoral immunity to Pneumocystis carinii in homosexual males, commercial plasma donors, and patients with acquired immunodeficiency syndrome. J. Clin. Microbiol. 25: 991 995.
72. Pifer, L. W.,, B. L. Wolf,, J. J. Weems, Jr.,, D. R. Woods,, C. C. Edwards,, and R. E. Joyner. 1988. Pneumocystis carinii antigenemia in acquired immunodeficiency syndrome. J. Clin. Microbiol. 26: 1357 1361.
73. Porter, S. B.,, and M. A. Sande. 1992. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N. Engl. J. Med. 327: 1643 1648.
74. Pratlong, F.,, J. P. Dedet,, P. Marty,, M. Portus,, M. Deniau,, J. Dereure,, P. Abranches,, J. Reynes,, A. Martini,, M. Lefebvre, et al. 1995. Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J. Infect. Dis. 172: 323 326.
75. Remington, J. S.,, R. McLeod,, and G. Desmonts,. 1995. Toxoplasmosis, p. 140 266. In J. S. Remington, and J. O. Klein (ed.), Infectious Diseases of the Fetus and Newborn Infants. W. B. Saunders, Philadelphia, Pa.
76. Sherer, R. 1998. Adherence and antiretroviral therapy in injection drug users. JAMA 280: 567 568.
77. Simon, F.,, P. Mauclere,, P. Roques,, I. Loussert-Ajaka,, M. C. Muller-Trutwin,, S. Saragosti,, M. C. Georges-Courbot,, F. Barre-Sinoussi,, and F. Brun-Vezinet. 1998. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 4: 1032 1037.
78. Sinibaldi, J.,, and I. De Ramirez. 1992. Incidence of congenital toxoplasmosis in live Guatemalan newborns. Eur. J. Epidemiol. 8: 516 520.
79. Skiest, D. J.,, W. Erdman,, W. E. Chang,, O. K. Oz,, A. Ware,, and J. Fleckenstein. 2000. SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS. J. Infect. 40: 274 281.
80. Smulian, A. G.,, M. J. Linke,, M. T. Cushion,, R. P. Baughman,, P. T. Frame,, M. N. Dohn,, M. L. White,, and P. D. Walzer. 1994. Analysis of Pneumocystis carinii organism burden, viability and antigens in bronchoalveolar lavage fluid in AIDS patients with pneumocystosis: correlation with disease severity. AIDS 8: 1555 1562.
81. Smulian, A. G.,, D. W. Sullivan,, M. J. Linke,, N. A. Halsey,, T. C. Quinn,, A. P. MacPhail,, M. A. Hernandez-Avila,, S. T. Hong,, and P. D. Walzer. 1993. Geographic variation in the humoral response to Pneumocystis carinii. J. Infect. Dis. 167: 1243 1247.
82. Stephenson, J. 2001. New HIV therapy guidelines. JAMA 285: 1281.
83. Subauste, C. S.,, M. Wessendarp,, A. G. Smulian,, and P. T. Frame. 2001. Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection. J. Infect. Dis. 183: 1722 1731.
84. UNAIDS and World Health Organization. 1998. AIDS Epidemic Update. UNAIDS, Geneva, Switzerland.
85. UNAIDS and World Health Organization. 2001. AIDS Epidemic Update. UNAIDS, Geneva, Switzerland.
86.UNAIDS and World Health Organization. 1998. Report on the Global HIV/AIDS Epidemic. UNAIDS, Geneva, Switzerland.
87. Walzer, P. D. 1986. Attachment of microbes to host cells: relevance of Pneumocystis carinii. Lab. Invest. 54: 589 592.
88. Wehle, K.,, M. Schirmer,, J. Dunnebacke- Hinz,, T. Kupper,, and P. Pfitzer. 1993. Quantitative differences in phagocytosis and degradation of Pneumocystis carinii by alveolar macrophages in AIDS and non-HIV patients in vivo. Cytopathology 4: 231 236.
89. Wolday, D.,, N. Berhe,, H. Akuffo,, and S. Britton. 1999. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol. Today 15: 182 187.
90. World Health Organization. 1995. Report on the Consultative Meeting on leishmaniasis/HIV Coinfection, p. 35. World Health Organization, Rome, Italy .

Tables

Generic image for table
Table 1

HIV infection data

Citation: Isturiz R, Gotuzzo E. 2002. Human Immunodeficiency Virus, , , and Species, p 389-400. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch20

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error